Loading...
•
Sep 30, 2020
Artivion Q3 2020 Earnings Report
CryoLife's third quarter results reflected the impact of the COVID-19 pandemic on procedure volumes, but the company saw sequential improvement month to month and completed the acquisition of Ascyrus Medical LLC.
Key Takeaways
CryoLife reported a decrease in total revenues by 4% compared to the third quarter of 2019. The company achieved a net loss of $2.9 million, or $0.08 per share, but a non-GAAP net income of $4.9 million, or $0.13 per share. CryoLife also completed the acquisition of Ascyrus Medical LLC.
Total revenues were $65.1 million, a 4% decrease compared to Q3 2019.
Net loss was ($2.9) million, or ($0.08) per share.
Non-GAAP net income was $4.9 million, or $0.13 per share.
Completed the acquisition of Ascyrus Medical LLC.
Forward Guidance
Due to continued uncertainties resulting from the COVID-19 pandemic, the Company is not issuing 2020 financial guidance at this time.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...